Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 348

1.

Acquired resistance mechanisms to afatinib in HER2-amplified gastric cancer cells.

Yoshioka T, Shien K, Takeda T, Takahashi Y, Kurihara E, Ogoshi Y, Namba K, Torigoe H, Sato H, Tomida S, Yamamoto H, Soh J, Fujiwara T, Toyooka S.

Cancer Sci. 2019 Jun 4. doi: 10.1111/cas.14089. [Epub ahead of print]

2.

Periarticular multimodal drug injection does not improves early postoperative analgesia compared with continuous interscalene brachial plexus block after arthroscopic rotator cuff repair: A retrospective single-center comparative study.

Toyooka S, Ito M, Kakinuma A, Kayama S, Watanabe K, Miyamoto W, Nakagawa T, Kawano H.

J Orthop Sci. 2019 May 29. pii: S0949-2658(19)30135-6. doi: 10.1016/j.jos.2019.04.013. [Epub ahead of print]

PMID:
31153741
3.

Critical role of the MCAM-ETV4 axis triggered by extracellular S100A8/A9 in breast cancer aggressiveness.

Chen Y, Sumardika IW, Tomonobu N, Kinoshita R, Inoue Y, Iioka H, Mitsui Y, Saito K, Ruma IMW, Sato H, Yamauchi A, Murata H, Yamamoto KI, Tomida S, Shien K, Yamamoto H, Soh J, Futami J, Kubo M, Putranto EW, Murakami T, Liu M, Hibino T, Nishibori M, Kondo E, Toyooka S, Sakaguchi M.

Neoplasia. 2019 Jul;21(7):627-640. doi: 10.1016/j.neo.2019.04.006. Epub 2019 May 14.

4.

A Prospective Cohort Study to Define the Clinical Features and Outcome of Lung Cancers Harboring HER2 Aberration in Japan (HER2-CS STUDY).

Ninomiya K, Hata T, Yoshioka H, Ohashi K, Bessho A, Hosokawa S, Ishikawa N, Yamasaki M, Shibayama T, Aoe K, Kozuki T, Harita S, Ueda Y, Murakami T, Fujimoto N, Yanai H, Toyooka S, Takata M, Hotta K, Kiura K; HER2-CS Network.

Chest. 2019 May 6. pii: S0012-3692(19)30031-5. doi: 10.1016/j.chest.2019.01.011. [Epub ahead of print]

PMID:
31072612
5.

Upregulation of mobility in pancreatic cancer cells by secreted S100A11 through activation of surrounding fibroblasts.

Mitsui Y, Tomonobu N, Watanabe M, Kinoshita R, Sumardika W, Youyi C, Murata H, Yamamoto KI, Sadahira T, Rodrigo AGH, Takamatsu H, Araki K, Yamauchi A, Yamamura M, Fujiwara H, Inoue Y, Futami J, Saito K, Iioka H, Kondo E, Nishibori M, Toyooka S, Yamamoto Y, Nasu Y, Sakaguchi M.

Oncol Res. 2019 Apr 17. doi: 10.3727/096504019X15555408784978. [Epub ahead of print]

PMID:
31046874
6.

Ganetespib in Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor-resistant Non-small Cell Lung Cancer.

Kurihara E, Shien K, Torigoe H, Takeda T, Takahashi Y, Ogoshi Y, Yoshioka T, Namba K, Sato H, Suzawa K, Yamamoto H, Soh J, Okazaki M, Shien T, Tomida S, Toyooka S.

Anticancer Res. 2019 Apr;39(4):1767-1775. doi: 10.21873/anticanres.13283.

PMID:
30952716
7.

Droplet digital PCR as a novel system for the detection of microRNA‑34b/c methylation in circulating DNA in malignant pleural mesothelioma.

Sato H, Soh J, Aoe K, Fujimoto N, Tanaka S, Namba K, Torigoe H, Shien K, Yamamoto H, Tomida S, Tao H, Okabe K, Kishimoto T, Toyooka S.

Int J Oncol. 2019 Jun;54(6):2139-2148. doi: 10.3892/ijo.2019.4768. Epub 2019 Apr 1.

PMID:
30942424
8.

Melanoma cell adhesion molecule is the driving force behind the dissemination of melanoma upon S100A8/A9 binding in the original skin lesion.

Chen Y, Sumardika IW, Tomonobu N, Winarsa Ruma IM, Kinoshita R, Kondo E, Inoue Y, Sato H, Yamauchi A, Murata H, Yamamoto KI, Tomida S, Shien K, Yamamoto H, Soh J, Liu M, Futami J, Sasai K, Katayama H, Kubo M, Putranto EW, Hibino T, Sun B, Nishibori M, Toyooka S, Sakaguchi M.

Cancer Lett. 2019 Jun 28;452:178-190. doi: 10.1016/j.canlet.2019.03.023. Epub 2019 Mar 21.

9.

Pulmonary resection in a prone position for lung cancer invading the spine.

Miyauchi S, Soh J, Shien K, Tanaka M, Yamamoto H, Ozaki T, Toyooka S.

Gen Thorac Cardiovasc Surg. 2019 Mar 21. doi: 10.1007/s11748-019-01113-7. [Epub ahead of print]

PMID:
30903520
10.

Anti-tumor effect of neratinib against lung cancer cells harboring HER2 oncogene alterations.

Ogoshi Y, Shien K, Yoshioka T, Torigoe H, Sato H, Sakaguchi M, Tomida S, Namba K, Kurihara E, Takahashi Y, Suzawa K, Yamamoto H, Soh J, Toyooka S.

Oncol Lett. 2019 Mar;17(3):2729-2736. doi: 10.3892/ol.2019.9908. Epub 2019 Jan 8.

11.

Extracellular S100A11 Plays a Critical Role in Spread of the Fibroblast Population in Pancreatic Cancers.

Takamatsu H, Yamamoto KI, Tomonobu N, Murata H, Inoue Y, Yamauchi A, Sumardika IW, Chen Y, Kinoshita R, Yamamura M, Fujiwara H, Mitsui Y, Araki K, Futami J, Saito K, Iioka H, Ruma IMW, Putranto EW, Nishibori M, Kondo E, Yamamoto Y, Toyooka S, Sakaguchi M.

Oncol Res. 2019 Jun 21;27(6):713-727. doi: 10.3727/096504018X15433161908259. Epub 2019 Mar 8.

PMID:
30850029
12.

Application of amplicon-based targeted sequencing with the molecular barcoding system to detect uncommon minor EGFR mutations in patients with treatment-naïve lung adenocarcinoma.

Namba K, Tomida S, Matsubara T, Takahashi Y, Kurihara E, Ogoshi Y, Yoshioka T, Takeda T, Torigoe H, Sato H, Shien K, Yamamoto H, Soh J, Tsukuda K, Toyooka S.

BMC Cancer. 2019 Feb 26;19(1):175. doi: 10.1186/s12885-019-5374-1.

13.

Impact of chronic lung allograft dysfunction, especially restrictive allograft syndrome, on the survival after living-donor lobar lung transplantation compared with cadaveric lung transplantation in adults: a single-center experience.

Sugimoto S, Yamamoto H, Kurosaki T, Otani S, Okazaki M, Yamane M, Toyooka S, Oto T.

Surg Today. 2019 Feb 21. doi: 10.1007/s00595-019-01782-0. [Epub ahead of print]

PMID:
30790054
14.

Tumour size determines both recurrence-free survival and disease-specific survival after surgical treatment for thymoma.

Okumura M, Yoshino I, Yano M, Watanabe SI, Tsuboi M, Yoshida K, Date H, Yokoi K, Nakajima J, Toyooka SI, Asamura H, Miyaoka E.

Eur J Cardiothorac Surg. 2019 Jul 1;56(1):174-181. doi: 10.1093/ejcts/ezz001.

PMID:
30783650
15.

Clinical outcome of patients with recurrent non-small cell lung cancer after trimodality therapy.

Suzawa K, Soh J, Takahashi Y, Sato H, Shien K, Yamamoto H, Kanazawa S, Kiura K, Miyoshi S, Toyooka S.

Surg Today. 2019 Jul;49(7):601-609. doi: 10.1007/s00595-019-1774-8. Epub 2019 Feb 8.

PMID:
30734881
16.

Neuroplastin-β mediates S100A8/A9-induced lung cancer disseminative progression.

Sumardika IW, Chen Y, Tomonobu N, Kinoshita R, Ruma IMW, Sato H, Kondo E, Inoue Y, Yamauchi A, Murata H, Yamamoto KI, Tomida S, Shien K, Yamamoto H, Soh J, Futami J, Putranto EW, Hibino T, Nishibori M, Toyooka S, Sakaguchi M.

Mol Carcinog. 2019 Jun;58(6):980-995. doi: 10.1002/mc.22987. Epub 2019 Feb 27.

PMID:
30720226
17.

SOCS3 overexpression in T cells ameliorates chronic airway obstruction in a murine heterotopic tracheal transplantation model.

Mesaki K, Yamane M, Sugimoto S, Fujisawa M, Yoshimura T, Kurosaki T, Otani S, Miyoshi S, Oto T, Matsukawa A, Toyooka S.

Surg Today. 2019 May;49(5):443-450. doi: 10.1007/s00595-018-1753-5. Epub 2019 Jan 7.

PMID:
30617600
18.

Lung transplant candidates with idiopathic pulmonary fibrosis and long-term pirfenidone therapy: Treatment feasibility influences waitlist survival.

Tanaka S, Miyoshi K, Higo H, Kurosaki T, Otani S, Sugimoto S, Yamane M, Kiura K, Toyooka S, Oto T.

Respir Investig. 2019 Mar;57(2):165-171. doi: 10.1016/j.resinv.2018.12.002. Epub 2018 Dec 30.

PMID:
30600175
19.

Activation of AXL as a Preclinical Acquired Resistance Mechanism Against Osimertinib Treatment in EGFR-Mutant Non-Small Cell Lung Cancer Cells.

Namba K, Shien K, Takahashi Y, Torigoe H, Sato H, Yoshioka T, Takeda T, Kurihara E, Ogoshi Y, Yamamoto H, Soh J, Tomida S, Toyooka S.

Mol Cancer Res. 2019 Feb;17(2):499-507. doi: 10.1158/1541-7786.MCR-18-0628. Epub 2018 Nov 21.

PMID:
30463991
20.

Newly developed anti-S100A8/A9 monoclonal antibody efficiently prevents lung tropic cancer metastasis.

Kinoshita R, Sato H, Yamauchi A, Takahashi Y, Inoue Y, Sumardika IW, Chen Y, Tomonobu N, Araki K, Shien K, Tomida S, Torigoe H, Namba K, Kurihara E, Ogoshi Y, Murata H, Yamamoto KI, Futami J, Putranto EW, Ruma IMW, Yamamoto H, Soh J, Hibino T, Nishibori M, Kondo E, Toyooka S, Sakaguchi M.

Int J Cancer. 2019 Jul 15;145(2):569-575. doi: 10.1002/ijc.31982. Epub 2018 Dec 14.

PMID:
30414170
21.

Dose-Volume Parameters Predict Radiation Pneumonitis after Surgery with Induction Concurrent Chemoradiotherapy for Non-small Cell Lung Cancer.

Ogata T, Katsui K, Yoshio K, Ihara H, Katayama N, Soh J, Kuroda M, Kiura K, Maeda Y, Toyooka S, Kanazawa S.

Acta Med Okayama. 2018 Oct;72(5):507-513. doi: 10.18926/AMO/56249.

22.

Feasibility of lung transplantation from donors mechanically ventilated for prolonged periods.

Sugimoto S, Kurosaki T, Otani S, Tanaka S, Hikasa Y, Yamane M, Toyooka S, Kobayashi M, Oto T.

Surg Today. 2019 Mar;49(3):254-260. doi: 10.1007/s00595-018-1730-z. Epub 2018 Oct 27.

PMID:
30368607
23.

exSSSRs (extracellular S100 soil sensor receptors)-Fc fusion proteins work as prominent decoys to S100A8/A9-induced lung tropic cancer metastasis.

Kinoshita R, Sato H, Yamauchi A, Takahashi Y, Inoue Y, Sumardika IW, Chen Y, Tomonobu N, Araki K, Shien K, Tomida S, Torigoe H, Namba K, Kurihara E, Ogoshi Y, Murata H, Yamamoto KI, Futami J, Putranto EW, Ruma IMW, Yamamoto H, Soh J, Hibino T, Nishibori M, Kondo E, Toyooka S, Sakaguchi M.

Int J Cancer. 2019 Jun 15;144(12):3138-3145. doi: 10.1002/ijc.31945. Epub 2018 Dec 4.

PMID:
30365872
24.

Donor-derived cell-free DNA is associated with acute rejection and decreased oxygenation in primary graft dysfunction after living donor-lobar lung transplantation.

Tanaka S, Sugimoto S, Kurosaki T, Miyoshi K, Otani S, Suzawa K, Hashida S, Yamane M, Oto T, Toyooka S.

Sci Rep. 2018 Oct 18;8(1):15366. doi: 10.1038/s41598-018-33848-3.

25.

Risk assessments for broncho-pleural fistula and respiratory failure after lung cancer surgery by National Clinical Database Japan.

Endo S, Ikeda N, Kondo T, Nakajima J, Kondo H, Shimada Y, Sato M, Toyooka S, Okada Y, Sato Y, Yoshino I, Okada M, Okumura M, Chida M, Fukuchi E, Miyata H.

Gen Thorac Cardiovasc Surg. 2019 Mar;67(3):297-305. doi: 10.1007/s11748-018-1022-y. Epub 2018 Oct 16.

PMID:
30328066
26.

Demographics, Safety and Quality, and Prognostic Information in Both the Seventh and Eighth Editions of the TNM Classification in 18,973 Surgical Cases of the Japanese Joint Committee of Lung Cancer Registry Database in 2010.

Okami J, Shintani Y, Okumura M, Ito H, Ohtsuka T, Toyooka S, Mori T, Watanabe SI, Date H, Yokoi K, Asamura H, Nagayasu T, Miyaoka E, Yoshino I; Japanese Joint Committee of Lung Cancer Registry.

J Thorac Oncol. 2019 Feb;14(2):212-222. doi: 10.1016/j.jtho.2018.10.002. Epub 2018 Oct 10.

PMID:
30316011
27.

A single-nucleotide polymorphism in a gene modulating glucocorticoid sensitivity is associated with the decline in total lung capacity after lung transplantation.

Yamamoto H, Sugimoto S, Tanaka S, Kurosaki T, Otani S, Yamane M, Taira N, Oto T, Toyooka S.

Surg Today. 2019 Mar;49(3):268-274. doi: 10.1007/s00595-018-1717-9. Epub 2018 Sep 18.

PMID:
30229311
28.

Inherited lung cancer syndromes targeting never smokers.

Yamamoto H, Yatabe Y, Toyooka S.

Transl Lung Cancer Res. 2018 Aug;7(4):498-504. doi: 10.21037/tlcr.2018.06.01. Review.

29.

Comparative mutational evaluation of multiple lung cancers by multiplex oncogene mutation analysis.

Takahashi Y, Shien K, Tomida S, Oda S, Matsubara T, Sato H, Suzawa K, Kurihara E, Ogoshi Y, Namba K, Yoshioka T, Torigoe H, Yamamoto H, Soh J, Toyooka S.

Cancer Sci. 2018 Nov;109(11):3634-3642. doi: 10.1111/cas.13797. Epub 2018 Oct 6.

30.

Crucial role of RAGE in inappropriate increase of smooth muscle cells from patients with pulmonary arterial hypertension.

Nakamura K, Sakaguchi M, Matsubara H, Akagi S, Sarashina T, Ejiri K, Akazawa K, Kondo M, Nakagawa K, Yoshida M, Miyoshi T, Ogo T, Oto T, Toyooka S, Higashimoto Y, Fukami K, Ito H.

PLoS One. 2018 Sep 4;13(9):e0203046. doi: 10.1371/journal.pone.0203046. eCollection 2018.

31.

Study Protocol: Phase-Ib Trial of Nivolumab Combined With Metformin for Refractory/Recurrent Solid Tumors.

Kubo T, Ninomiya T, Hotta K, Kozuki T, Toyooka S, Okada H, Fujiwara T, Udono H, Kiura K.

Clin Lung Cancer. 2018 Nov;19(6):e861-e864. doi: 10.1016/j.cllc.2018.07.010. Epub 2018 Aug 9.

PMID:
30172698
32.

Combined inhibition of MEK and PI3K pathways overcomes acquired resistance to EGFR-TKIs in non-small cell lung cancer.

Sato H, Yamamoto H, Sakaguchi M, Shien K, Tomida S, Shien T, Ikeda H, Hatono M, Torigoe H, Namba K, Yoshioka T, Kurihara E, Ogoshi Y, Takahashi Y, Soh J, Toyooka S.

Cancer Sci. 2018 Oct;109(10):3183-3196. doi: 10.1111/cas.13763. Epub 2018 Sep 14.

33.

Combined effect of cabozantinib and gefitinib in crizotinib-resistant lung tumors harboring ROS1 fusions.

Kato Y, Ninomiya K, Ohashi K, Tomida S, Makimoto G, Watanabe H, Kudo K, Matsumoto S, Umemura S, Goto K, Ichihara E, Ninomiya T, Kubo T, Sato A, Hotta K, Tabata M, Toyooka S, Maeda Y, Kiura K.

Cancer Sci. 2018 Oct;109(10):3149-3158. doi: 10.1111/cas.13752. Epub 2018 Sep 11.

34.

Myoepithelioma occurring in the posterior mediastinum harboring EWSR1 rearrangement: a case report.

Habu T, Soh J, Toji T, Shien K, Niman E, Namba K, Sato H, Yamamoto H, Sugimoto S, Yamane M, Toyooka S.

Jpn J Clin Oncol. 2018 Sep 1;48(9):851-854. doi: 10.1093/jjco/hyy100.

PMID:
30053180
35.

Embigin Promotes Prostate Cancer Progression by S100A4-Dependent and-Independent Mechanisms.

Ruma IMW, Kinoshita R, Tomonobu N, Inoue Y, Kondo E, Yamauchi A, Sato H, Sumardika IW, Chen Y, Yamamoto KI, Murata H, Toyooka S, Nishibori M, Sakaguchi M.

Cancers (Basel). 2018 Jul 23;10(7). pii: E239. doi: 10.3390/cancers10070239.

36.

SPRED2 deficiency may lead to lung ischemia-reperfusion injury via ERK1/2 signaling pathway activation.

Okada M, Yamane M, Yamamoto S, Otani S, Miyoshi K, Sugimoto S, Matsukawa A, Toyooka S, Oto T, Miyoshi S.

Surg Today. 2018 Dec;48(12):1089-1095. doi: 10.1007/s00595-018-1696-x. Epub 2018 Jul 18.

PMID:
30022248
37.

[Induction Chemoradiotherapy for Locally Advanced Non-small Cell Lung Cancer].

Miura A, Soh J, Shien K, Yamamoto H, Toyooka S.

Kyobu Geka. 2018 Apr;71(4):270-277. Japanese.

PMID:
29755100
38.

Low-risk donor lungs optimize the post-lung transplant outcome for high lung allocation score patients.

Kurosaki T, Miyoshi K, Otani S, Imanishi K, Sugimoto S, Yamane M, Kobayashi M, Toyooka S, Oto T.

Surg Today. 2018 Oct;48(10):928-935. doi: 10.1007/s00595-018-1670-7. Epub 2018 May 11.

PMID:
29752531
39.

Short hookwire placement under imaging guidance before thoracic surgery: A review.

Iguchi T, Hiraki T, Matsui Y, Fujiwara H, Masaoka Y, Uka M, Gobara H, Toyooka S, Kanazawa S.

Diagn Interv Imaging. 2018 Oct;99(10):591-597. doi: 10.1016/j.diii.2018.04.001. Epub 2018 May 7.

PMID:
29747897
40.

Is Surgery after Chemoradiotherapy Feasible in Lung Cancer Patients with Superior Vena Cava Invasion?

Sato H, Soh J, Hotta K, Katsui K, Kanazawa S, Kiura K, Toyooka S.

Ann Thorac Cardiovasc Surg. 2018 Jun 20;24(3):131-138. doi: 10.5761/atcs.oa.18-00027. Epub 2018 Apr 20.

41.

Airway complications have a greater impact on the outcomes of living-donor lobar lung transplantation recipients than cadaveric lung transplantation recipients.

Sugimoto S, Yamane M, Otani S, Kurosaki T, Okahara S, Hikasa Y, Toyooka S, Kobayashi M, Oto T.

Surg Today. 2018 Sep;48(9):848-855. doi: 10.1007/s00595-018-1663-6. Epub 2018 Apr 21.

PMID:
29680912
42.

Bone-to-bone integrations were complete within 5 months after anatomical rectangular tunnel anterior cruciate ligament reconstruction using a bone-patellar tendon-bone graft.

Masuda H, Taketomi S, Inui H, Shimazaki N, Nishihara N, Toyooka S, Kawano H, Nakagawa T.

Knee Surg Sports Traumatol Arthrosc. 2018 Dec;26(12):3660-3666. doi: 10.1007/s00167-018-4938-y. Epub 2018 Apr 16.

PMID:
29663013
43.

[Clinical Implementation of Precision Medicine].

Tomida S, Toyooka S.

Gan To Kagaku Ryoho. 2018 Apr;45(4):601-604. Japanese.

PMID:
29650812
44.

Tumor-suppressive effect of LRIG1, a negative regulator of ErbB, in non-small cell lung cancer harboring mutant EGFR.

Torigoe H, Yamamoto H, Sakaguchi M, Youyi C, Namba K, Sato H, Shien K, Soh J, Suzawa K, Tomida S, Tsukuda K, Miyoshi S, Toyooka S.

Carcinogenesis. 2018 May 3;39(5):719-727. doi: 10.1093/carcin/bgy044.

PMID:
29546323
45.

Therapeutic strategies for afatinib-resistant lung cancer harboring HER2 alterations.

Torigoe H, Shien K, Takeda T, Yoshioka T, Namba K, Sato H, Suzawa K, Yamamoto H, Soh J, Sakaguchi M, Tomida S, Tsukuda K, Miyoshi S, Toyooka S.

Cancer Sci. 2018 May;109(5):1493-1502. doi: 10.1111/cas.13571. Epub 2018 Apr 15.

46.

A Multicenter Randomized Controlled Study of Paclitaxel plus Carboplatin versus Oral Uracil-Tegafur as the Adjuvant Chemotherapy in Resected Non-Small Cell Lung Cancer.

Toyooka S, Okumura N, Nakamura H, Nakata M, Yamashita M, Tada H, Kajiwara S, Watanabe N, Okada M, Sakamoto J, Aoe M, Soh J, Miyoshi S, Hotta K, Matsuo K, Date H.

J Thorac Oncol. 2018 May;13(5):699-706. doi: 10.1016/j.jtho.2018.02.015. Epub 2018 Mar 2.

PMID:
29505900
47.

Antitumor activity of pan-HER inhibitors in HER2-positive gastric cancer.

Yoshioka T, Shien K, Namba K, Torigoe H, Sato H, Tomida S, Yamamoto H, Asano H, Soh J, Tsukuda K, Nagasaka T, Fujiwara T, Toyooka S.

Cancer Sci. 2018 Apr;109(4):1166-1176. doi: 10.1111/cas.13546. Epub 2018 Mar 25.

48.

Second primary cancer in survivors of locally advanced non-small cell lung cancer treated with concurrent chemoradiation followed by surgery.

Makimoto G, Kubo T, Oze I, Ohashi K, Hotta K, Tabata M, Soh J, Toyooka S, Katsui K, Takigawa N, Tanimoto M, Kiura K.

Jpn J Clin Oncol. 2018 Mar 1;48(3):287-290. doi: 10.1093/jjco/hyy003.

PMID:
29409038
49.

Unique circulating microRNAs in relation to EGFR mutation status in Japanese smoker male with lung adenocarcinoma.

Ito S, Kamoto Y, Sakai A, Sasai K, Hayashi T, Toyooka S, Katayama H.

Oncotarget. 2017 Sep 30;8(70):114685-114697. doi: 10.18632/oncotarget.21425. eCollection 2017 Dec 29.

50.

Therapeutic potential of targeting S100A11 in malignant pleural mesothelioma.

Sato H, Sakaguchi M, Yamamoto H, Tomida S, Aoe K, Shien K, Yoshioka T, Namba K, Torigoe H, Soh J, Tsukuda K, Tao H, Okabe K, Miyoshi S, Pass HI, Toyooka S.

Oncogenesis. 2018 Jan 24;7(1):11. doi: 10.1038/s41389-017-0017-3.

Supplemental Content

Loading ...
Support Center